tiprankstipranks
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Similar Stocks

Compare
336 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immuneering
$1.76
$53.10M
-73.25%
2 Buy
0 Hold
1 Sell
Moderate Buy
Alnylam Pharma
$250.59
$32.49B
61.94%
15 Buy
3 Hold
0 Sell
Strong Buy
Exelixis
$36.85
$9.82B
19.80
77.85%
12 Buy
8 Hold
0 Sell
Moderate Buy
Incyte
$72.11
$13.81B
265.89
19.53%
6 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$484.24
$123.34B
12.59%
14 Buy
12 Hold
1 Sell
Moderate Buy
Blueprint Medicines
$92.25
$6.03B
5.72%
11 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IMRX
Immuneering
1.76
-4.66
-72.59%
ALNY
Alnylam Pharma
250.59
87.78
53.92%
EXEL
Exelixis
36.85
16.14
77.93%
INCY
Incyte
72.11
11.20
18.39%
VRTX
Vertex Pharmaceuticals
484.24
57.46
13.46%
BPMC
Blueprint Medicines
92.25
6.25
7.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis